Clinical Trial Update: Individualized Drug Treatment for Treating Patients With Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update on individualized drug treatment for pancreatic cancer was terminated, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED | Results posted: 2018-08-27